Cleveland Clinic orthopaedic surgeons review a recent case of a 45-year-old woman who presented with osteonecrosis of the femoral head. the surgeons discuss risk factors, their approach and more.
Research led by Nicolas S. Piuzzi, MD, staff in Cleveland Clinic’s Department of Orthopaedic Surgery, examined how physicians may better predict if and when a patient is at increased risk of developing contralateral arthroplasty after a total knee or hip replacement. These new insights may be key to developing earlier interventions for at-risk patients.
Analysis suggests morbidly obese patients may have more complications, such as readmission, reoperation and superficial infection, following joint replacement procedures.
New study evaluates the impact of preoperative functional status on short-term outcomes following total hip arthroplasty.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A validated machine learning tool accurately predicts the orthopaedic episode of care, building payment models that account for patient-specific risk and comorbidities.
With increasing use of robotic-arm assisted joint replacement technology at Cleveland Clinic, this Q&A explores how the system is transforming three joint replacements procedures.
A new protocol for the preoperative evaluation and optimization of elderly hip fracture patients increases the percentage of patients getting to the OR in less than 48 hours. By doing so, outcomes improved and hospital costs decreased.
With an array of VTE chemoprophylactic agents – from low-molecular-weight heparin to warfarin to newer anticoagulants – available for patients undergoing TJA, how do you choose? Is simple ASA enough?
Based on study of more than 28,000 TJA patients, presurgical ABO blood group testing looks like an inexpensive way to identify patents at increased risk for symptomatic postoperative VTE.
Intraoperative use of tranexamic acid for appropriate THA and TKA cases trimmed Cleveland Clinic’s transfusion rate from 33 to 18 percent in little over a year. Read about the program’s rationale and benefits.